Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | AZN |
---|---|---|
09:32 ET | 45997 | 64.97 |
09:33 ET | 30352 | 65.005 |
09:35 ET | 11334 | 64.98 |
09:37 ET | 20565 | 64.8818 |
09:39 ET | 15076 | 64.94 |
09:42 ET | 17987 | 65.015 |
09:44 ET | 19335 | 64.97 |
09:46 ET | 11041 | 65.03 |
09:48 ET | 19387 | 65.005 |
09:50 ET | 10721 | 65.1001 |
09:51 ET | 19676 | 65.03 |
09:53 ET | 15744 | 64.9179 |
09:55 ET | 8559 | 64.885 |
09:57 ET | 22529 | 64.83 |
10:00 ET | 33973 | 64.86 |
10:02 ET | 27153 | 64.81 |
10:04 ET | 19474 | 64.79 |
10:06 ET | 23416 | 64.705 |
10:08 ET | 17974 | 64.66 |
10:09 ET | 14509 | 64.67 |
10:11 ET | 12836 | 64.75 |
10:13 ET | 6947 | 64.74 |
10:15 ET | 21406 | 64.73 |
10:18 ET | 14655 | 64.79 |
10:20 ET | 17421 | 64.78 |
10:22 ET | 13588 | 64.78 |
10:24 ET | 11122 | 64.74 |
10:26 ET | 19992 | 64.715 |
10:27 ET | 9922 | 64.7401 |
10:29 ET | 15135 | 64.76 |
10:31 ET | 23558 | 64.735 |
10:33 ET | 22547 | 64.8 |
10:36 ET | 22233 | 64.77 |
10:38 ET | 7373 | 64.76 |
10:40 ET | 21722 | 64.76 |
10:42 ET | 5982 | 64.755 |
10:44 ET | 9624 | 64.8 |
10:45 ET | 16635 | 64.86 |
10:47 ET | 12535 | 64.89 |
10:49 ET | 6993 | 64.865 |
10:51 ET | 22680 | 64.87 |
10:54 ET | 18269 | 64.89 |
10:56 ET | 13523 | 64.92 |
10:58 ET | 10322 | 64.86 |
11:00 ET | 9728 | 64.89 |
11:02 ET | 11635 | 64.895 |
11:03 ET | 6449 | 64.87 |
11:05 ET | 7258 | 64.905 |
11:07 ET | 8706 | 64.85 |
11:09 ET | 7454 | 64.8598 |
11:12 ET | 12483 | 64.835 |
11:14 ET | 11655 | 64.81 |
11:16 ET | 13295 | 64.84 |
11:18 ET | 15733 | 64.88 |
11:20 ET | 19555 | 64.875 |
11:21 ET | 25905 | 64.845 |
11:23 ET | 11607 | 64.87 |
11:25 ET | 18031 | 64.875 |
11:27 ET | 13040 | 64.95 |
11:30 ET | 7723 | 65 |
11:32 ET | 70194 | 64.95 |
11:34 ET | 16773 | 64.965 |
11:36 ET | 12282 | 64.9425 |
11:38 ET | 11240 | 64.83 |
11:39 ET | 4798 | 64.84 |
11:41 ET | 9231 | 64.85 |
11:43 ET | 5529 | 64.83 |
11:45 ET | 9583 | 64.805 |
11:48 ET | 11585 | 64.825 |
11:50 ET | 2968 | 64.8 |
11:52 ET | 13683 | 64.845 |
11:54 ET | 4140 | 64.885 |
11:56 ET | 10111 | 64.885 |
11:57 ET | 13957 | 64.92 |
11:59 ET | 10639 | 64.96 |
12:01 ET | 4642 | 64.945 |
12:03 ET | 4390 | 64.97 |
12:06 ET | 9858 | 64.98 |
12:08 ET | 12905 | 64.985 |
12:10 ET | 1598 | 65 |
12:12 ET | 2482 | 65.01 |
12:14 ET | 1231 | 65.005 |
12:15 ET | 10160 | 64.985 |
12:17 ET | 6921 | 64.9709 |
12:19 ET | 13100 | 64.955 |
12:21 ET | 9785 | 64.93 |
12:24 ET | 7235 | 64.93 |
12:26 ET | 2534 | 64.899 |
12:28 ET | 5331 | 64.94 |
12:30 ET | 6414 | 64.935 |
12:32 ET | 10906 | 64.93 |
12:33 ET | 2257 | 64.97 |
12:35 ET | 6849 | 64.985 |
12:37 ET | 5606 | 64.94 |
12:39 ET | 3117 | 64.95 |
12:42 ET | 3165 | 64.935 |
12:44 ET | 8486 | 64.95 |
12:46 ET | 13248 | 64.955 |
12:48 ET | 13814 | 64.98 |
12:50 ET | 4631 | 64.97 |
12:51 ET | 7092 | 65.005 |
12:53 ET | 2748 | 65.011 |
12:55 ET | 9435 | 65.01 |
12:57 ET | 3329 | 65.01 |
01:00 ET | 2059 | 65.01 |
01:02 ET | 6712 | 64.985 |
01:04 ET | 1880 | 64.98 |
01:06 ET | 5767 | 64.975 |
01:08 ET | 25503 | 64.97 |
01:09 ET | 1664 | 64.965 |
01:11 ET | 6093 | 64.94 |
01:13 ET | 5748 | 64.97 |
01:15 ET | 3590 | 64.975 |
01:18 ET | 5022 | 64.985 |
01:20 ET | 8093 | 64.965 |
01:22 ET | 2043 | 64.9611 |
01:24 ET | 3524 | 64.96 |
01:26 ET | 3051 | 64.95 |
01:27 ET | 5689 | 64.92 |
01:29 ET | 7506 | 64.93 |
01:31 ET | 9736 | 64.91 |
01:33 ET | 1383 | 64.91 |
01:36 ET | 12862 | 64.87 |
01:38 ET | 2899 | 64.89 |
01:40 ET | 2366 | 64.8985 |
01:42 ET | 7000 | 64.86 |
01:44 ET | 15647 | 64.82 |
01:45 ET | 8189 | 64.82 |
01:47 ET | 3398 | 64.85 |
01:49 ET | 6905 | 64.8731 |
01:51 ET | 4447 | 64.885 |
01:54 ET | 7806 | 64.885 |
01:56 ET | 5030 | 64.8699 |
01:58 ET | 4453 | 64.865 |
02:00 ET | 3162 | 64.86 |
02:02 ET | 7549 | 64.855 |
02:03 ET | 7279 | 64.865 |
02:05 ET | 6126 | 64.85 |
02:07 ET | 8419 | 64.825 |
02:09 ET | 4245 | 64.82 |
02:12 ET | 15012 | 64.855 |
02:14 ET | 2593 | 64.885 |
02:16 ET | 2455 | 64.89 |
02:18 ET | 9002 | 64.87 |
02:20 ET | 5222 | 64.85 |
02:21 ET | 8727 | 64.855 |
02:23 ET | 6692 | 64.835 |
02:25 ET | 5602 | 64.84 |
02:27 ET | 5488 | 64.835 |
02:30 ET | 4014 | 64.835 |
02:32 ET | 7212 | 64.8802 |
02:34 ET | 5056 | 64.845 |
02:36 ET | 13307 | 64.905 |
02:38 ET | 9909 | 64.88 |
02:39 ET | 5974 | 64.86 |
02:41 ET | 15488 | 64.9 |
02:43 ET | 1200 | 64.925 |
02:45 ET | 7135 | 64.95 |
02:48 ET | 21304 | 64.965 |
02:50 ET | 10710 | 65 |
02:52 ET | 17732 | 64.975 |
02:54 ET | 10179 | 64.95 |
02:56 ET | 11921 | 64.93 |
02:57 ET | 21492 | 64.955 |
02:59 ET | 7648 | 64.97 |
03:01 ET | 7103 | 64.995 |
03:03 ET | 3882 | 64.985 |
03:06 ET | 6349 | 64.9701 |
03:08 ET | 11630 | 64.955 |
03:10 ET | 6036 | 64.96 |
03:12 ET | 7998 | 64.99 |
03:14 ET | 5267 | 64.98 |
03:15 ET | 2216 | 64.985 |
03:17 ET | 11643 | 64.99 |
03:19 ET | 940 | 64.985 |
03:21 ET | 14059 | 65.015 |
03:24 ET | 8511 | 65.025 |
03:26 ET | 9782 | 65.035 |
03:28 ET | 7069 | 65.03 |
03:30 ET | 6278 | 65.035 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
AstraZeneca PLC | 199.5B | 34.4x | +2.29% |
Novartis AG | 222.2B | 28.1x | +0.02% |
Bristol-Myers Squibb Co | 101.9B | 12.7x | +4.53% |
Sanofi SA | 118.1B | 12.0x | +17.46% |
Abbvie Inc | 253.2B | 39.6x | +13.33% |
GSK plc | 74.2B | 9.7x | +9.56% |
AstraZeneca PLC is a science-led biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory and immunology. Its pipeline forms a portfolio of investigational therapies in various stages of clinical development and includes the Alexion Rare Disease portfolio comprising approximately 178 projects. Its key marketed oncology products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Zoladex, Faslodex and others. Its rare diseases products include Soliris, Ultomiris, Strensiq and Kanuma. Its BioPharmaceuticals products include Farxiga, Lokelma, Crestor, Breztri and others. Its geographical segments include United Kingdom, Rest of Europe, the Americas and Asia, Africa and Australasia. It is also focused on discovering, developing, and manufacturing of T-cell receptor therapies.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $199.5B |
---|---|
Revenue (TTM) | $45.0B |
Shares Outstanding | 3.1B |
Dividend Yield | 2.23% |
Annual Dividend Rate | 1.4500 USD |
Ex-Dividend Date | 08-10-23 |
Pay Date | 09-11-23 |
Beta | 0.50 |
EPS | $1.89 |
Book Value | $11.95 |
P/E Ratio | 34.4x |
Price/Sales (TTM) | 4.4 |
Price/Cash Flow (TTM) | 17.4x |
Operating Margin | 17.90% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.